Holen Sie sich die Stockscreener-App
11.40
0.18%
-0.02
Handel nachbörslich:
11.95
0.55
+4.82%
Schlusskurs vom Vortag:
$11.42
Offen:
$11.32
24-Stunden-Volumen:
1.47M
Relative Volume:
0.54
Marktkapitalisierung:
$1.30B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-242.30M
KGV:
-4.5968
EPS:
-2.48
Netto-Cashflow:
$-192.10M
1W Leistung:
-5.55%
1M Leistung:
+57.89%
6M Leistung:
+22.45%
1J Leistung:
+21.79%
1-Tages-Spanne:
$11.10
$11.64
1-Wochen-Bereich:
$11.10
$12.41
52-Wochen-Spanne:
$3.72
$12.97
Cogent Biosciences Inc Stock (COGT) Company Profile
Firmenname
Cogent Biosciences Inc
Sektor
Branche
Telefon
617-945-5576
Adresse
275 WYMAN STREET, WALTHAM
Vergleichen Sie COGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
11.40 | 1.59B | 0 | -242.30M | -192.10M | -2.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-11 | Herabstufung | Needham | Buy → Hold |
| 2024-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Eingeleitet | Citigroup | Buy |
| 2023-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-12-08 | Eingeleitet | JP Morgan | Overweight |
| 2023-04-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-09 | Fortgesetzt | Jefferies | Buy |
| 2020-12-23 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Cogent Biosciences Inc Aktie (COGT) Neueste Nachrichten
Is it the right time to buy Cogent Biosciences Inc. stockMarket Forecast Data Feed From AI Tools - jammulinksnews.com
What institutional investors are buying Cogent Biosciences Inc. stockRetirement Planning Insights For 2025 - jammulinksnews.com
What is the risk reward ratio of investing in Cogent Biosciences Inc. stockWealth Building Trend Scanner For 2025 - jammulinksnews.com
Published on: 2025-07-30 07:09:48 - metal.it
What makes Cogent Biosciences Inc. stock price move sharplyAccurate Buy Point for Momentum Stocks Detected - metal.it
Key External Factors That Drive Cogent Biosciences Inc. Stock Price MovementsRisk Controlled Picks With Real Returns Outlined - metal.it
Cogent Biosciences Inc. Shows Early Signs of Technical StrengthSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Cogent Biosciences Rated as a Buy at Citi on Robust Pipeline - MSN
How Efficient Is Cogent Biosciences Inc. at Controlling Operating CostsIntraday Trend Analysis for Fast Gains Released - metal.it
Why Cogent Biosciences Inc. stock attracts strong analyst attentionAlpha Driven Watchlist With Alerts Published - metal.it
Published on: 2025-07-28 05:03:28 - jammulinksnews.com
What is the dividend policy of Cogent Biosciences Inc. stockMaximize returns with data-driven strategies - jammulinksnews.com
What are Cogent Biosciences Inc. company’s key revenue driversMaximize returns with smart investment plans - jammulinksnews.com
How volatile is Cogent Biosciences Inc. stock compared to the marketAchieve breakthrough gains with smart trades - jammulinksnews.com
Should I hold or sell Cogent Biosciences Inc. stock in 2025Achieve consistent profits with proven methods - jammulinksnews.com
When is Cogent Biosciences Inc. stock expected to show significant growthOutstanding capital appreciation - jammulinksnews.com
Is Cogent Biosciences Inc. a Top Dividend Stock to Watch in 2025Momentum Swing Watchlist - metal.it
Published on: 2025-07-28 06:33:38 - jammulinksnews.com
What are the latest earnings results for Cogent Biosciences Inc.Triple-digit wealth increases - jammulinksnews.com
Intrinsic Value of Cogent Biosciences Inc. Stock: Is It Undervalued or OvervaluedFree Short-Term Stock Picks - metal.it
Is Cogent Biosciences Inc. stock overhyped or has real potentialTremendous portfolio expansion - jammulinksnews.com
10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen - Insider Monkey
What analysts say about Cogent Biosciences Inc. stockPhenomenal capital appreciation - jammulinksnews.com
What drives Cogent Biosciences Inc. stock priceExceptional trading performance - Autocar Professional
2 Biotech and 2 Tech Stocks Insiders Are Scooping Up Now - 24/7 Wall St.
Is Cogent Biosciences Inc. a good long term investmentMarket-beating performance - jammulinksnews.com
Cogent Biosciences Inc. Stock Analysis and ForecastGame-changing returns - jammulinksnews.com
Citi Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛
Cogent Biosciences (NASDAQ:COGT) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
3 Stocks With Sky-High Overbought Signals: QuantumScape, Opendoor, Cogent Flash RSI Red Flags - Benzinga
When (COGT) Moves Investors should Listen - news.stocktradersdaily.com
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cogent Biosciences Inc-Aktie (COGT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pinnow Cole | Chief Commercial Officer |
Jan 14 '25 |
Buy |
7.60 |
43,750 |
332,412 |
45,848 |
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):